机构

• 上海药物研究所 [130]
• 沈阳自动化研究所 [44]
• 合肥物质科学研究院 [36]
• 水生生物研究所 [21]
• 上海生物化学与细胞... [14]
• 昆明动物研究所 [14]
• 更多

采集方式

• OAI收割 [354]
• iSwitch采集 [17]

内容类型

• 期刊论文 [332]
• 会议论文 [21]
• 学位论文 [12]
• 项目 [3]
• 专著章节 [2]
• 专著 [1]
• 更多

发表日期

• 2024 [5]
• 2023 [7]
• 2022 [21]
• 2021 [26]
• 2020 [31]
• 2019 [13]
• 更多

学科主题

• Oncology [5]
• Pharmacolo... [4]
• Immunology [3]
• Science & ... [3]
• Biochemist... [2]
• Chemistry,... [2]
• 更多

筛选

浏览/检索结果: 共371条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 Dihydrocelastrol induces cell death and suppresses angiogenesis through BCR/AP-1/junb signalling in diffuse large B cell lymphoma 期刊论文  OAI收割 ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 卷号: 754, 页码: 11 作者:  Lai, Yue;  Guo, Shushan;  Tang, Qiongwei;  Chang, Gaomei;  Zhang, Hui   |  收藏  |  浏览/下载：1/0  |  提交时间：2024/05/07 Dihydrocelastrol  Angiogenesis  Apoptosis  Jun B  p65   Pharmacokinetics, mass balance, and metabolism of [14C]envonalkib (TQ-B3139), a novel ALK tyrosine kinase inhibitor, in healthy Chinese subjects 期刊论文  OAI收割 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 页码: 11 作者:  Ma, Sheng;  Wang, Xin;  Yan, Shu;  Miao, Liyan;  Wan, Xiaojing   |  收藏  |  浏览/下载：2/0  |  提交时间：2024/05/07 Envonalkib  TQ-B3139  Pharmacokinetics  Mass balance  Excretion  Metabolism   Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 6, 页码: 4804-4818 作者:  Suo, Yuying;  Du, Daohai;  Chen, Chao;  Zhu, Hongwen;  Wang, Xiongjun   |  收藏  |  浏览/下载：3/0  |  提交时间：2024/05/07 Proteomics analysis of histone deacetylase inhibitor-resistant solid tumors reveals resistant signatures and potential drug combinations 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2024, 页码: 11 作者:  Hao, Bing-bing;  Ma, Ke;  Xu, Jun-yu;  Fan, Ru-feng   |  收藏  |  浏览/下载：20/0  |  提交时间：2024/03/25 solid tumor  histone deacetylase inhibitor  vorinostat (SAHA)  drug resistance  proteomics   Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2024, 卷号: 67, 期号: 4, 页码: 2884-2906 作者:  Liang, Xuewu;  Yu, Haolan;  Liang, Renwen;  Feng, Zhuanghui;  Saidahmatov, Abdusaid   |  收藏  |  浏览/下载：19/0  |  提交时间：2024/04/09 Berberine derivative DCZ0358 induce oxidative damage by ROS-mediated JNK signaling in DLBCL cells 期刊论文  OAI收割 INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 卷号: 125, 页码: 15 作者:  Feng, Qilin;  Hu, Ke;  Hu, Huifang;  Lu, Yumeng;  Zhang, Hui   |  收藏  |  浏览/下载：28/0  |  提交时间：2024/01/16 DLBCL  ROS  DNA damage  JNK  Mitochondrial dysfunction   Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文  OAI收割 BLOOD ADVANCES, 2023, 卷号: 7 作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe   |  收藏  |  浏览/下载：17/0  |  提交时间：2023/11/10 Design, synthesis and pharmacological evaluation of 2,3-dihydrobenzo-furan IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 256, 页码: 16 作者:  Chen, Yun;  Ning, Yi;  Chen, Zhiwei;  Xue, Yaping;  Wu, Qingyun   |  收藏  |  浏览/下载：12/0  |  提交时间：2023/10/17 Apoptosis  Diffuse large B-Cell lymphoma  Interleukin-1 receptor associated kinase 4  Structure-based drug design  2  3-Dihydrobenzofuran   Novel thieno[2,3-b]quinoline-procaine hybrid molecules: A new class of allosteric SHP-1 activators evolved from PTP1B inhibitors 期刊论文  OAI收割 CHINESE CHEMICAL LETTERS, 2023, 卷号: 34, 期号: 8, 页码: 6 作者:  Xu, Lei;  Xuyan, Xuyang;  Minmi, Minmin;  Wang, Zhiji;  Shee, Chao   |  收藏  |  浏览/下载：31/0  |  提交时间：2023/10/17 Activator  PTPs  Inhibitor  Thieno[2  b ]quinoline derivatives  Diffuse large B-cell lymphoma   ARID3a from the ARID family: structure, role in autoimmune diseases and drug discovery 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 12 作者:  Guo, Cheng-cen;  Xu, H. Eric;  Ma, Xiong   |  收藏  |  浏览/下载：9/0  |  提交时间：2023/10/17 transcription factors  ARID  ARID3a  autoimmune diseases  systemic lupus erythematosus  primary biliary cholangitis